Ivermectine Xiromed

Ivermectin, the active ingredient in Ivermectine Xiromed, is an anthelmintic presented as an oral formulation for oral use. It treats a range of parasitic infections including onchocerciasis, strongyloidiasis, scabies, lymphatic filariasis and other helminth infections.

GNH USA supplies Ivermectine Xiromed as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ivermectin is an anthelmintic that targets a variety of parasitic infections.

- Onchocerciasis: reduces microfilariae load and prevents disease progression. - Strongyloidiasis: eliminates intestinal larvae and prevents dissemination. - Scabies: eradicates Sarcoptes scabiei mites, relieving skin infestation. - Lymphatic filariasis: clears filarial worms, reducing morbidity. - Other helminth infections: treats various nematode infections, improving patient outcomes.

Ivermectin may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nausea - Diarrhea - Dizziness - Itching

Serious or Rare Side Effects: - Severe skin reactions such as Stevens‑Johnson syndrome - Neurological effects including seizures - Hepatotoxicity - Anaphylaxis

Before prescribing Ivermectine Xiromed, clinicians should consider several safety measures.

- Assess for known hypersensitivity: avoid in patients with documented ivermectin allergy. - Monitor liver function: use caution in patients with hepatic impairment. - Review concomitant CNS‑active drugs: potential for enhanced neurotoxicity. - Use with caution in patients with compromised blood‑brain barrier. - Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Ivermectin can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Strong CYP3A4 inducers (e.g., rifampicin) may reduce ivermectin exposure. - P‑glycoprotein inhibitors (e.g., verapamil) may increase ivermectin levels. - Concurrent use with other neurotoxic antiparasitics may heighten neurotoxicity.

Moderate Interactions (Monitor Closely): - Macrolide antibiotics (e.g., erythromycin) may modestly raise ivermectin concentrations. - Warfarin may have enhanced anticoagulant effect; monitor INR closely.